Drug
Tj102
Tj102: highest development phase Phase 1/2, developed by Phrontline Biopharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Phrontline Biopharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| TJ102 NCT07778498 | Phase 1/2 | Ovarian Cancer |
Latest
No recent events.
Follow Tj102 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.